Analysis

PremiumFeatures

OCT New England 2026: Tackling the Patient Enrolment Crisis

Low enrolment in clinical trials places pressure on sponsors and regulators to rethink trial design in ways that better inform…

Frankie Fattorini

Features

Podcast: An investor’s guide to preparing your clinical data package

PremiumFeatures

Speed and collaboration vital for Europe’s regrowth as clinical trial hub

Comment

How sponsors can accelerate contracting and budget negotiations

Features

Podcast: ESMO26: Major readouts from the 2026 congress

PremiumFeatures

Navigating the complexities of running clinical trials amid disruption

Projects

Darzalex Faspro for the Treatment of Light Chain (AL) Amyloidosis, US

Features

ESMO26: US and FDA movements to improve oncology trials a positive signal

Analysis

How real-world evidence can directly support innovation

Analysis

PPD affects races similarly, inequities lie in mental healthcare

GlobalData Healthcare

Analysis

Psychedelic treatments for mental health: Is there substance behind the hype?

News

Can Elon Musk’s Neuralink be trusted to put chips in your brain?

News

IRA lawsuits will be vital test of US’ ability to regulate pharma market

Analysis

How sovereign wealth funds are affecting industries and macroeconomics

Analysis

How sovereign wealth funds are affecting industries and macroeconomics

Analysis

Why does Kuwait struggle to attract FDI?

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close